February 28, 2022

New Clinician Spotlight: Avni Finn

Avni Finn, MD, MBA, a retina surgeon, has joined Vanderbilt University Medical Center and the Vanderbilt Eye Institute as assistant professor of Ophthalmology and Visual Sciences.

 

Avni Finn, MD, MBA, a retina surgeon, has joined Vanderbilt University Medical Center and the Vanderbilt Eye Institute as assistant professor of Ophthalmology and Visual Sciences.

Avni Finn, MD, MBA

Her clinical interests include treating medical and surgical diseases of the retina, including conditions such as age-related macular degeneration, diabetic retinopathy, retinal detachment and macular holes.

Her research interests include investigating imaging biomarkers that can better aid in personalizing medical and surgical care for patients with retinal diseases.

“We are thrilled to have Dr. Finn joining our retina division. Avni has stellar credentials and brings great clinical experience to Vanderbilt,” said Paul Sternberg Jr., MD, G.W. Hale Professor of Ophthalmology and Visual Sciences and chair of the department. “She will be a wonderful addition to the Vanderbilt Eye Institute.”

Finn received her undergraduate degree in human biology with a minor in Spanish from Stanford University. She earned a medical degree and Master of Business Administration from Dartmouth, followed by residency training at Massachusetts Eye and Ear Infirmary at Harvard Medical School, then a fellowship in medical and surgical diseases of the retina and vitreous at Duke University.

During her fellowship she received the Ronald G. Michels Fellowship Foundation award, given to select outstanding fellows in vitreoretinal surgery. She is a member of the American Society of Retina Specialists, the Association for Research in Vision and Ophthalmology and the American Academy of Ophthalmology.

“I was interested in coming to Vanderbilt because of the collaborative nature of the faculty and also, because of my research interests, the opportunity for collaboration between the biomedical engineering department and the Medical Center,” Finn said. “I hope to build cross-discipline collaborations to help us better understand retinal diseases and leverage these biomedical engineering technologies to inform surgical decision making.”

Patients can be referred to Finn by calling the Vanderbilt Eye Institute at 615-936-2020.